What’s the news: Millions more people in the U.S. will soon be able to receive a booster dose of the COVID-19 vaccines from Moderna and Johnson & Johnson (J&J). This comes almost a month after a ...

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

Last month, the FDA approved Moderna's respiratory syncytial virus vaccine, the second approved product for the COVID-19 vaccine maker. The RSV shot is the first messenger-RNA-based vaccine not ...

Moderna Inc said on Thursday its COVID-19 vaccine was about 93% effective through six months after the second dose, showing hardly any change from the efficacy reported in its original clinical trial.

1-lineage for the COVID-19 vaccines (2024-2025 formula ... the FDA advised that they wait at least two months before getting ...

In the past three months, MRNA stock has lost ... and mRNA-1083 (COVID-19 plus and influenza combination vaccine). Moderna also plans to file a regulatory filing for mResvia seeking label ...

The period between getting the Moderna COVID-19 vaccine and the first booster shot has been shortened to five months from six for people ages 18 and up, the Food and Drug Administration says.

Although the protection against COVID-19 still offers a significant ... their cash runway to at least 16 months, presuming no revenues in 2025. Overall, Moderna's transition from pandemic to ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled ...

Moderna (MRNA) announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union, Norway and North ...